BY AllChem Asia
We constantly monitor the statistics of the increasing export products of Indian pharmaceuticals, produced in India and exported to the other countries. This time we will talk about the Indian company AllChem Asia, which produces a fairly wide range of products. Despite the fact that the company is quite young, – it started its work with respect to the production of medical products in 2015, – it managed to take 43% of exported products to Malaysia. This is a good indicator for a fairly young company. AllChem Asia company is growing rapidly. AllChem Asia is working so far under the terms of Marketing Agreement with one of the large stand leading pharmaceutical companies in India. According to our information, the company plans to have its own facilities for the production of its drugs in the near future.
Statistics also showed that in 2021, sales of the antibiotic Gentamicid of the aminoglycide series in pharmacy chains accounted for 19%, more than in 2020. With other Indian manufacturers, AllChem Asia outcompletes its competitors by 7.5%.
This year, the company wants to increase the range of Oncological drugs, due to the high demand for this group of products.
The increase will take place up to 8 items. It will also produce drugs for Prostate Cancer. Prostate Cancer is one of the most common oncological diseases. It accounts for more than 14% of all malignant tumors diagnosed in men.
AllChem Asia | Video
The company makes a significant contribution to global health. Over the past two years, as the world was battling the Covid-19 pandemic, despite restrictions, the company’s industry has shown its commitment and strength by delivering essential medicines to more than 60 countries. With an export value of USD 14.77 million.(2020-21) Indian pharmaceutical industry products continue to improve the health of patients worldwide.
To strengthen its position in the health care market, a company’s industry must build on its fundamental strengths by taking a quantum leap towards innovation.
Building expertise in specialized and innovative pharmaceutical are as such as complex generics, new biologics and those with unmet therapeutic needs will be the next step in fueling the company’s growth engine.
India continues to be an innovation hub and provides innovative, quality and affordable medicines to patients in our country and around the world, fulfilling the philosophy of Kutumbakam (the world is one family).
